SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Zonagen (zona) - good buy?

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Dauntless who wrote (2865)3/20/1998 12:10:00 PM
From: Hank  Read Replies (1) of 7041
 
If Viagra is approved, the FDA will only approve Vasomax if

1) Vasomax is shown to be more efficacious or

2) Vasomax is shown to be efficacious in patients that do not respond to Viagra.

I have not heard nor seen anything regarding the Vasomax clinical trials that would indicate Vasomax would qualify for FDA approval on either of these counts. Make no mistake about it. This is a money driven business. Large drug companies do not spend millions of dollars developing potential block buster drugs just so they can sell them in places like Mexico. The developed countries of the world ARE their primary targets because that is where they will make money. If SGP truely believed they could get approval for Vasomax in the US, Canada, or Europe, then that is where their initial efforts would be focused.

Here's a trivia question for you or anybody that thinks they can answer-

How many new drugs with a billion dollar a year potential have been marketed by major US based pharmaceutical companies in places like Mexico and/or other third world countries BEFORE being submitted for approval in the US, Canada, or Europe?

Here's a hint- the answer has the number zero in it.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext